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Effects of anti-reflux surgery on chronic cough
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This two-group prospective study evaluated the effect of anti-reflux surgery (fundoplication) on 24 patients with
severe gastro-oesophageal reflux disease (GORD) and concomitant asthma (n¼13) or chronic cough (n=11).
Twenty-four hour oesophageal pH monitoring and lung function tests (FEV1, FVC) were done before and within 1
year after anti-reflux surgery. A diary was kept by the patient during the 4-week period prior to surgery and during
4-week periods 6 and 12 months postoperatively, with daily monitoring of peak expiratory flow rate, respiratory
and reflux symptoms and medication. In non-asthmatic patients, coughing was reduced by 47% and 80% during
the day and night, respectively, 12 months after surgery (P50?01). Concomitant hoarseness and expectoration were
also significantly reduced (P50?05). No effect on lung function was seen. In patients with asthma, small, non-
significant reductions in asthma symptom scores and consumption of rescue medication were seen. Twenty-two
patients were completely free from their GORD symptoms after surgery. In conclusion, anti-reflux surgery in
patients with GORD had a more favourable effect on concomitant cough than concomitant asthma.
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Many studies have shown a close relationship between
gastro-oesophageal reflux disease (GORD) and asthma
(1–4), and also between GORD and chronic cough (5–7).
Suggested mechanisms behind a causal relationship be-
tween GORD and respiratory symptoms are aspiration
(2,8), oesophagobronchial reflexes (9) and mis-swallowing
(6).
Several studies have shown an improvement of respira-
tory symptoms following anti-reflux medication or surgery
(1, 5–7, 10–20). Most surgical studies have a rather short
follow-up period and lack long-term data on lung function
and respiratory symptoms.
The aim of the present study was to prospectively
evaluate the effect of anti-reflux surgery (fundoplication)
on chronic cough and asthma in subjects with GORD using
a patient diary in the manner used to document the effects
of a medical intervention.Received 13 March 2000 and accepted in revised form 1 August
2000. Published online 9 October 2000.
Correspondence should be addressed to: Tommy Ekstro¨m, M.D.,
Norbergsgatan 5 C, SE-223 54 Lund, Sweden. Fax: +46 46
337575.
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STUDY POPULATION
Twenty-four patients with severe GORD who had simulta-
neous asthma or chronic cough were the subjects of this
study. All patients had a hiatal hernia, endoscopic
oesophagitis, pathological result of 24-h pH monitoring
of the oesophagus or pathological reflux test at manometry.
The indication for anti-reflux surgery was persistent
symptoms of GORD and oesophagitis despite at least 6
months of treatment with proton pump inhibitors, H2
blockers and antacids. Thirteen patients had asthma
according to the definition of the American Thoracic
Society (21) and 11 patients had chronic cough with (n=10)
or without (n=1) sputum production and hoarseness (8/11)
for more than 1 year before surgery. Eight patients in each
group had a history of reflux-associated respiratory
symptoms. All patients with asthma were on regular
medication with inhaled corticosteroids (n=11). Asthma
was excluded in patients with chronic cough by spirometry,
reversibility testing and peak expiratory flow monitoring at
home for 3 weeks. Furthermore, no signs of wheeze, attacks
of dyspnoea or history of airway hyperresponsiveness to
airborne irritants were accepted in this group of patients.
Demographic data for the study population are given in
Table 1.# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. Demographic data and current medication in
patients with asthma (n=13) or persistent cough (n=11)
prior to anti-reflux surgery
Patients with
asthma
Patients with
cough
Male/female 7/6 2/9
Age, years (range) 56 (45–70) 55 (40–72)
Current smokers 2 0
Inhaled corticosteroids 11 1
Oral b2-agonist 3 1
Oral theophyllines 3 0
Omeprazole 8 7
H2-blockers 5 4
Antacids 13 11
Duration of respiratory
symptoms, years (range)
13?5 (1–31) 9?5 (3–30)
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pH monitoring
Twenty-four-hour pH monitoing of the oesophagus was
performed prior to surgery and 6 months postoperatively,
using an antimony pH electrode placed 5 cm above the
upper border of the lower oesophageal sphincter. All
patients were hospitalized during the monitoring period
and received a special acid-free diet. Acid-suppressive
medication was withdrawn 5 days prior to investigation.
At our institution, the normal upper limit for GOR is
defined as reflux less than 1% of the day (22).
No manometry was done postoperatively.
Surgical technique
Twenty patients were operated on with transabdominal and
four patients with laparascopic fundoplication. In all
patients the fundus of the stomach was mobilized and all
short vessels to the spleen were divided. Crural repair was
performed behind the oesophagus. A short, floppy, 3608
fundoplication was performed in 15 cases. In nine subjects a
posterior, partial (2708) fundoplication was performed.
Patient diary
Over a 4-week period prior to anti-reflux surgery and over
4-week periods 6 and 12 months postoperatively all patients
recorded their daily respiratory symptoms in a standard
fashion. Patients with asthma recorded asthma symptoms
experienced during the day and at night on a scale of 0–3,
where 0 indicated no symptoms, 1=mild, 2=moderate and
3 = severe symptoms. The daily use of inhaled rescue
bronchodilators and any change in regular asthma medica-
tion were also recorded in the diary. Patients wereinstructed not to change their regular asthma medication
unless absolutely necessary. No attempt was made to taper
off asthma medication during the follow-up period in order
to avoid the effect of reduced medication on asthma
outcome. Peak expiratory flow (PEF) measurements were
made immediately upon waking and before retiring to bed.
Mini-Wright peak flow meters were used and the highest
value of three measurements was recorded.
Non-asthmatic patients graded their daily symptoms of
cough, sputum production and hoarseness on a scale of
0–3, where 0=no symptoms, 1=mild, 2=moderate and
3=severe symptoms. Any medication was recorded on the
diary card. PEF measurements were not performed in this
group of patients.
Furthermore, all subjects in the study recorded daily
symptoms of GORD (heartburn and regurgitation) on a
scale of 0–3 in their diary pre- and postoperatively. Anti-
reflux medication was allowed prior to surgery because of
the severity of the GORD.
Lung function tests
Forced expiratory flow in 1 sec (FEV1) and forced vital
capacity (FVC) were measured prior to surgery and 6 and
12 months postoperatively, using a dry spirometer,
(Vitalograph, U.K).
STATISTICAL ANALYSIS
The Wilcoxon’s signed rank test was used for comparison
of data before and after anti-reflux surgery. A level of
P50?05 was considered statistically significant.
ETHICS
The Human Research Committee approved the study and
informed consent was obtained from each subject.
Results
All patients completed the study. Four subjects failed to fill
in their diary cards during either the 6- (n=3) or 12-month
(n=1) follow-up period. All patients were included in the
final analyses.
Patients with chronic cough showed a significant
improvement in all respiratory symptom parameters after
anti-reflux surgery (Table 2, Fig. 1). Day cough was
decreased by 47% and nocturnal cough by 80%. Five
patients (45%) became completely cough-free at night and
two of these were also cough-free during the day. Lung
function did not change during the study (Table 2, Fig. 2).
Total reflux time, heartburn and regurgitation were
significantly reduced after surgery (Table 2, Fig. 3).
In patients with asthma there was a tendency towards
better asthma control after surgery, even if the improve-
ment in asthma symptom score and the less frequent use of
rescue medication did not reach statistical significance
TABLE 2. Lung function, respiratory symptoms, 24-h oesophageal pH monitoring and symptoms of GORD before and after
anti-reflux surgery in 11 patients with chronic cough. Mean values (+SEM) are given.
Before surgery 6 months postoperatively 12 months postoperatively
FEV1 lmin
71 (% predicted) 94?8 (5?7) 97?8 (4?1) 94?5 (5?8)
FVC lmin71 (% predicted) 98?6 (5?1) 102?3 (3?7) 100?2 (5?3)
Cough score day 1?52 (0?17) 0?60* (0?19) 0?81** (0?17)
Cough score night 1?25 (0?27) 0?31 (0?17) 0?25** (0?15)
Hoarseness score 1?04 (0?22) 0?25* (0?17) 0?19* (0?12)
Expectoration score 1?14 (0?18) 0?39* (0?29) 0?40* (0?13)
Heartburn score day 0?80 (0?26) 0* (0) 0?05* (0?05)
Heartburn score night 0?54 (0?21) 0 (0) 0?02* (0?02)
Regurgitation score 1?34 (0?32) 0* (0) 0?03** (0?03)
24-h pH monitoring
Total reflux time, % 10?97 (4?63) 0?05** (0?05) — —
*P50?05; **P50?01.
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3, Fig. 2). Two patients were completely relieved of asthma
symptoms at night, both having a history of reflux-
associated respiratory symptoms.
Total reflux time and symptoms of GORD were
significantly reduced after surgery (Table 3, Fig. 3). All
patients except three were able to maintain their regular
asthma medication throughout the study. Two patients
increased their dose of bronchodilators and one stopped
regular use of inhaled corticosteroids. The outcome of these
three patients did not differ from that of the group as a
whole.
Discussion
The present study shows a dramatic effect of fundoplication
on cough, sputum production and hoarseness in non-
asthmatic patients with GORD. Our findings are in
accordance with those of other authors, who have reported
good relief from respiratory symptoms after anti-reflux
surgery in patients with chronic cough (6–7, 23–26).FIG. 1. Combined score of disease control before (BS) and
12 months after surgery (AS) in patients with asthma (&)
(symptoms and use of rescue medication day and night)
and in patients with cough (&) (cough day and night,
hoarseness and expectoration). Mean values +SEM are
given.On the other hand, patients with asthma showed no
significant improvement in this study, even if symptom
scores and use of rescue medication were slightly reduced 12
months after surgery. These findings differ from those of
other reports (1–2,15–17,19). Sontag et al. (15) reported
that six out of 13 patients had complete relief of their
asthma after surgery. Tardif et al. (17) reported improve-
ment in asthma control in 50% (five out of 10) of asthmatic
patients following anti-reflux surgery. In a study by Perrin-
Fayolle et al. (16) patients with asthma and GORD were
followed for 5 years: 25% had total resolution of
respiratory symptoms, 16% were markedly improved,
25% had moderate improvement and 34% noted no
change. However, negative results have also been reported.
Ruth et al. (23) evaluated 53 patients after anti-reflux
surgery. Of the 20 patients with simultaneous pulmonary
symptoms, only patients with chronic cough improved,
whilst asthmatic patients were unaffected by the surgical
intervention.
There may be several reasons behind the discrepancy
between our findings and those reported in the literature.
The number of patients with asthma may have beenFIG. 2. FEV1 before surgery (BS) and 12 months after
surgery (AS) in patients with asthma (&) and chronic
cough (&) Mean values +SEM are given.
TABLE 3. Lung function, respiratory symptoms, use of rescue medication, 24-h oesophageal pH monitoring and symptoms of
GORD before and after anti-reflux surgery in 13 patients with asthma [mean values (+SEM) are given]
Before surgery 6 months postoperatively 12 months postoperatively
FEV1 lmin
71 (% preditcted) 65?6 (4?9) 64?6 (6?7) 61?9 (5?8)
FVC lmin71(% preditcted) 77?0 (3?8) 70?5 (6?4) 71?9 (6?1)
PEFR morning lmin71 401 (50?2) 397 (57?0) 408 (50?2)
PEFR evening lmin71 419 (49?2) 412 (57?5) 422 (49?4)
Asthma score, night 1?28 (0?30) 1?02 (0?37) 0?88 (0?26)
Asthma score, day 0?73 (0?27) 0?89 (0?31) 0?67 (0?32)
Rescue medication, no. of Puffs
during the night
0?35 (0?24) 0?39 (0?17) 0?20 (0?14)
Puffs during the day 2?06 (0?52) 1?45 (0?76) 1?60 (0?56)
Heartburn score day 0?93 (0?23) 0?11 (0?11) 0** (0)
Heartburn score night 0?56 (0?19) 0?08 (0?08) 0* (0)
Regurgitation score 1?45 (0?35) 0* (0) 0* (0)
24-h pH monitoring
Total reflux time, % 6?05 (1?58) 0?34** (0?18) — —
*P50?05; **P50?01.
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surgical procedure. Other investigators, however, have
reported a positive outcome of anti-reflux surgery in small
groups of patients (15,17). It could be argued that that was
a selection bias, since our patients were not selected for
surgery due to severity of asthma or a strong suspicion of a
causal relationship between the GORD and asthma but for
the severity of GORD. However, most patients had a
history of reflux-associated respiratory symptoms and
several of them had symptomatic asthma despite extensive
medication. Another explanation could be differences in
surgical technique despite the fact that acid reflux in our
study was totally abolished after fundoplication.
A more plausible explanation for the poor response to
fundoplication in the asthmatic group of patients may be
that anti-reflux medication was given over a long period of
time (46months) prior to surgery, which may have
reduced the room for improvement. We previously (18)
studied 48 patients with asthma and symptoms of GORFIG. 3. Total reflux score (heartburn day and night plus
regurgitation) in patients with asthma (&) and chronic
cough (&) before (BS) and 12 months after surgery (AS).
Mean values +SEM are given.who were given ranitidine or placebo over a 4-week period.
A significant reduction in nocturnal asthma symptoms and
rescue inhalations was seen after ranitidine treatment. In a
study by Harding et al. (20), acid-suppressive therapy with
omeprazole was received for 3 months by patients with
asthma and GORD. Seventy-three percent of the patients
responded to therapy. Asthma symptoms were reduced by
57% and morning PEF improved by 8% compared to
baseline.
The literature on anti-reflux treatment in patients with
chronic cough is more consistent with our results (5–7, 23–
26). The effect of fundoplication seems to be more obvious
in patients with chronic cough than in subjects with asthma.
The reason behind this may be that asthma is a more
complex disease, with several trigger factors involved.
Amelioration of GORD cannot be expected to abolish all
symptoms of asthma, while cough as a single symptom may
be easier to control by surgical intervention. There is also a
possibility that patients with chronic cough respond more
favourably to anti-reflux surgery than to acid-suppressive
medication. In a study by Tibbling et al. (6), treatment with
omeprazole did not significantly reduce coughing or other
respiratory symptoms, whereas fundoplication in these
patients totally relieved coughing in 27 of 34 subjects. The
authors concluded that aspiration due to mis-swallowing
was the probable cause of the respiratory problems in the
population studied. It was believed that distal anchoring of
the longitudinal oesophageal muscle by surgery restores the
delicate coordination between deglutition, the opening of
the upper oesophageal sphincter and the epiglottic closure
of the laryngeal entrance, thereby reducing the likelyhood
for aspiration. The importance of oesophageal body
motility as a predictor of successful outcome after anti-
reflux surgery has also been stressed by other authors (7).
In conclusion, anti-reflux surgery in patients with GORD
had more favourable effect on concomitant cough than
1170 T. EKSTRO¨M AND K.-E. JOHANSSONconcomitant asthma. Patient selection and the nature of the
disease may be crucial factors regarding response to
therapy.
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